129 related articles for article (PubMed ID: 6291446)
1. [Metabolism of insulin and immunoreactive insulin-like substances (proinsulin, HWIRI) in vivo in man].
Villaume C; Beck B; Pointel JP; Drouin P; Debry G
Ann Endocrinol (Paris); 1982; 43(1):15-21. PubMed ID: 6291446
[TBL] [Abstract][Full Text] [Related]
2. Portal, hepatic and peripheral insulin immunoreactive substances before and after removal of an insulinoma.
Villaume C; Beck B; Pointel JP; Drouin P; Debry G
J Endocrinol Invest; 1982; 5(5):315-21. PubMed ID: 6296220
[TBL] [Abstract][Full Text] [Related]
3. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma.
Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R
J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076
[TBL] [Abstract][Full Text] [Related]
4. Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements.
Alsever RN; Roberts JP; Gerber JG; Mako ME; Rubenstein AH
Ann Intern Med; 1975 Mar; 82(3):347-50. PubMed ID: 163611
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and localization of an insulinoma with inappropriate hypoglycemia in relation to the level of immunoreactive insulin using gel chromatographic separation.
Kakita K; Horino M
Exp Clin Endocrinol; 1985 Apr; 85(2):167-75. PubMed ID: 2990974
[TBL] [Abstract][Full Text] [Related]
6. Plasma insulin response to various secretagogues in insulinoma.
Ohneda A; Kobayashi T; Nihei J
Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
[TBL] [Abstract][Full Text] [Related]
7. Effects of liver and kidney on high molecular weight immunoreactive insulin (HWIRI), proinsulin (PI) and insulin (I) in man.
Villaume C; Beck B; Pointel JP; Drouin P; Debry G
Horm Metab Res; 1981 Oct; 13(10):583-4. PubMed ID: 7028592
[No Abstract] [Full Text] [Related]
8. Rapid assay of insulin in portosplenic blood for insulinoma.
Yao CZ; Zeng XJ; Niu ZP
Chin Med J (Engl); 1984 Jan; 97(1):57-60. PubMed ID: 6329612
[No Abstract] [Full Text] [Related]
9. Acinar-islet cell carcinoma presenting as insulinoma.
Shimoike T; Goto M; Nakano I; Sato T; Migita Y; Ito T; Yanase T; Sezai S; Suzuki T; Nawata H
J Gastroenterol; 1997 Dec; 32(6):830-5. PubMed ID: 9430026
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive insulin assay in insulinoma.
Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
[No Abstract] [Full Text] [Related]
11. Degradation during storage of high molecular weight immunoreactive insulin (HWIRI) and proinsulin (PLC) in extracts of Benign insulinomas and adjacent pancreatic tissue.
Villaume C; Beck B; Pointel JP; Drouin P; Debry G
Horm Metab Res; 1981 Sep; 13(9):528-9. PubMed ID: 6271661
[No Abstract] [Full Text] [Related]
12. Heterogeneity of circulating insulin and proinsulin in man.
Horwitz DL; Rubenstein AH
Isr J Med Sci; 1974 Oct; 10(10):1201-11. PubMed ID: 4373412
[No Abstract] [Full Text] [Related]
13. [Insulinoma with hyperproinsulinemia: a two cases report].
Gury H; Rio F; Neamtu D; Boivin S
Ann Endocrinol (Paris); 2002 Jun; 63(3):240-2. PubMed ID: 12193882
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of high molecular weight insulins in insulinoma patients.
Permutt M; Biesbroeck J; Chyn R
J Clin Endocrinol Metab; 1977 Mar; 44(3):536-44. PubMed ID: 190261
[TBL] [Abstract][Full Text] [Related]
15. [Monitoring effect of rapid determination of portal and splenic venous blood insulin in surgical operation for insulinoma].
Yao CZ
Zhonghua Yi Xue Za Zhi; 1983 Nov; 63(11):667-9. PubMed ID: 6326973
[No Abstract] [Full Text] [Related]
16. Mithramycin for hypoglycemia in malignant insulinoma.
Kiang DT; Frenning DH; Bauer GE
N Engl J Med; 1978 Jul; 299(3):134-5. PubMed ID: 207984
[No Abstract] [Full Text] [Related]
17. 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.
Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
Ann Endocrinol (Paris); 1984; 45(3):155-60. PubMed ID: 6098216
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
Hanssen KF; Torjesen PA; Heding LG
Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
[No Abstract] [Full Text] [Related]
19. Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.
Pérez-Pevida B; Idoate MÁ; Fernández-Landázuri S; Varo N; Escalada J
Endocr Pathol; 2016 Mar; 27(1):50-4. PubMed ID: 26801953
[TBL] [Abstract][Full Text] [Related]
20. Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma.
Imamura M; Hattori Y; Nishida O; Honda T; Shimada Y; Miyahara T; Wagata T; Baba N; Tobe T
Pancreas; 1990 Jul; 5(4):467-73. PubMed ID: 2166285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
